133 related articles for article (PubMed ID: 7905741)
1. Destructive networks in AIDS.
Kennedy JR
Immunol Today; 1993 Dec; 14(12):615. PubMed ID: 7905741
[No Abstract] [Full Text] [Related]
2. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.
Zinkernagel RM; Hengartner H
Immunol Today; 1994 Jun; 15(6):262-8. PubMed ID: 7915115
[TBL] [Abstract][Full Text] [Related]
3. Immunopathogenesis and immunotherapy in AIDS virus infections.
Letvin NL; Walker BD
Nat Med; 2003 Jul; 9(7):861-6. PubMed ID: 12835706
[TBL] [Abstract][Full Text] [Related]
4. A little learning is a dangerous thing; especially for a cytotoxic T-lymphocyte.
Griffiths PD
Rev Med Virol; 2003; 13(5):275-6. PubMed ID: 12931338
[No Abstract] [Full Text] [Related]
5. A strategy for prophylactic vaccination against HIV.
Salk J; Bretscher PA; Salk PL; Clerici M; Shearer GM
Science; 1993 May; 260(5112):1270-2. PubMed ID: 8098553
[No Abstract] [Full Text] [Related]
6. [HIV without AIDS but no AIDS without HIV].
Soriano V; González-Lahoz J
Med Clin (Barc); 1995 Jul; 105(5):172-3. PubMed ID: 7630229
[No Abstract] [Full Text] [Related]
7. Cellular immune responses to HIV.
McMichael AJ; Rowland-Jones SL
Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
[TBL] [Abstract][Full Text] [Related]
8. The lucky ones. How do some HIV-positive people avoid getting AIDS?
Beardsley T
Sci Am; 1994 May; 270(5):20, 24, 28. PubMed ID: 7910979
[No Abstract] [Full Text] [Related]
9. Cytotoxic T-cell recognition of HIV proteins and peptides.
Nixon DF; McMichael AJ
AIDS; 1991 Sep; 5(9):1049-59. PubMed ID: 1718319
[No Abstract] [Full Text] [Related]
10. Potential pitfalls on the road to an effective HIV vaccine.
Schwartz DH
Immunol Today; 1994 Feb; 15(2):54-7. PubMed ID: 7908803
[TBL] [Abstract][Full Text] [Related]
11. [Influencing factors of single-platform method of flow cytometry in the detection of immunophenotype of peripheral blood lymphocytes in HIV/AIDS patients].
Zhang FJ; Yao J; Zhao HX; Feng X; Lu LH; Han N; Liu ZY; Lin H
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):124-6. PubMed ID: 15774223
[No Abstract] [Full Text] [Related]
12. Mucosal immunity, HIV transmission, and AIDS.
Miller CJ; McGhee JR; Gardner MB
Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249
[No Abstract] [Full Text] [Related]
13. The value of preserving HIV-specific immune responses.
Kaufmann DE; Rosenberg ES
J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulation in HIV-1 infection in the HAART era.
Imami N; Sullivan AK; Gotch FM
J HIV Ther; 2001 Nov; 6(4):77-84. PubMed ID: 11740408
[No Abstract] [Full Text] [Related]
15. MHC-I non-restricted cytotoxic activity in Macaca sylvana experimentally inoculated with HIV2 and SIV/mac.
Charaf B; Sanhadji K; Sekkat S; Farouqui B; Touraine JL; Benslimane A
Thymus; 1993 Aug; 22(1):1-12. PubMed ID: 7905683
[TBL] [Abstract][Full Text] [Related]
16. HIV-infected humans, but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells.
Zarling JM; Ledbetter JA; Sias J; Fultz P; Eichberg J; Gjerset G; Moran PA
J Immunol; 1990 Apr; 144(8):2992-8. PubMed ID: 1969880
[TBL] [Abstract][Full Text] [Related]
17. [The infection and immunity of HIV: hope and thought].
Shang H
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):220-2. PubMed ID: 17425861
[No Abstract] [Full Text] [Related]
18. Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination.
Plata F; Dadaglio G; Chenciner N; Hoffenbach A; Wain-Hobson S; Michel F; Langlade-Demoyen P
Immunodefic Rev; 1989; 1(3):227-46. PubMed ID: 2698642
[TBL] [Abstract][Full Text] [Related]
19. AIDS patients can tolerate a substantial loss of CD4 cells.
Oncology (Williston Park); 1992 Jan; 6(1):97-8. PubMed ID: 1346966
[No Abstract] [Full Text] [Related]
20. Immunoregulation, immune defects, and clinical strategies in HIV infection.
Lane HC
Mt Sinai J Med; 1992 May; 59(3):244-52. PubMed ID: 1534869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
